Quantum Medical Transport Inc (OTCMKTS:DRWN) has introduced its Pre-ICO launch to commence offering its Tokens in support of its unique QuantH medical blockchain technology assignment. The company has been contacted by several investors showing interest in acquiring their tokens in support of the firm’s growth plan.

Interested shareholders should review and download company’s white paper/prospectus. The company has released its SAFT subscription agreement on its website for prospective shareholders to download and complete and send to the company. Its buy button on the online platform will be functional once they have obtained the address code from respective service provider.

The buzz

Quantum Medical Transport prospectus offering is being presented to verified accredited investors just in the U.S. pursuant to Rule 506(c). This offering is being done to international shareholders outside the United States following Reg S. Prospective investors may get accredited investor certification via visiting: www.earlyiq.com and filing their verification to the firm in order to enroll to the private placement subscription Exhibit ‘B’ in the prospectus.

This ICO is for an aggregate gross proceeds of $50 million from the sale of Digital Coins Securities or Tokens. The minimum subscription sum is $25,000 at a buy price of $1 per token. QuantH Medical Blockchain Technology will allow secure encryption data sharing that will be HIPPA acquiescent. The Pre-ICO Sale begins has started and will close on March 20, 2018, post that the company will issue the full ICO on March 20, 2018, which will open through April 15, 2018.

As per the update, any Tokens that are not issued will be burned. Quantum team consider this technology platform can be a notable revenue generator for the firm as healthcare professionals like physicians, medical facilities counting nursing homes they currently service can use the subscription service that will utilize a multi-layer, multi-signature secure key code via a set of customized nodes to send data.

LEAVE A REPLY

Please enter your comment!
Please enter your name here